Private Investors

Truffle capital

Truffle Capital is a private equity and venture capital firm based in Paris, France. It invests in growth-stage companies through buyouts, as well as early-stage and later-stage companies through venture capital investments.

sofipôle sa

Sofipôle SA is a financial services firm. It is a subsidiary of S.R.I.W. SA (Société Régionale d’Investissement de Wallonie), which is a public investment company owned by the Walloon Region of Belgium.


newton biocapital

Newton Biocapital is a venture capital firm that focuses on investing in biotech and life science sectors. The firm’s mission is to mature innovation and support the growth of its portfolio companies to create value for patients, society, local ecosystems, and investors.


Fund+ is an open-ended fund that invests in innovative life sciences companies with a focus on Belgium. The fund was founded in 2015 and is based in Leuven, Belgium. Fund+ aims to create sustainable investments in long-term equity. The fund prefers to invest in seed-stage, early-stage, and later-stage companies.

sms investment sa

liver live saving

SMS Investments SA is a consultancy firm specializing in management and investment services. It is a foreign entity that was incorporated on October 1, 2012, in Belgium. The company is dedicated to utilizing its expertise in capital markets to assist its clients in realizing their financial objectives and aspirations.



Families office

liver live saving

Group of private investors who have decided to personally invest in our project because they believe in our vision and our ability to achieve our goal.

Shinsei Capital Partners, Ltd.

Shinsei Capital Partners (SCP) is a Japanese VC firm specialized in cutting edge biotechnologies for patients. SCP’s mission is to help such research outcomes to be funded and to catalyze the translation of innovative medicines serving the needs of the patients. SCP contributes to the most promising technology innovations through the hands-on leverage of their deep knowledge of the sector and unique experiences in finance and drug development.


Sambrinvest is a venture capital firm and wealth management company based in Gosselies and Charleroi, Belgium. It was founded in 1985 and has over 270 companies in its portfolio, with €160M under management.

Governmental Investors

Wallonie Entreprendre

Wallonie Entreprendre is a public regional promotional institution for the Belgian region of Wallonia founded in 2002.


Sopartec is a technology transfer and investment company affiliated with the Université catholique de Louvain (UCLouvain) in Belgium. It manages the intellectual property of the university and commercializes it through licenses, partnerships, and the creation of new companies.

Invest.BW is a venture capital firm based in Louvain-la-Neuve, Belgium. The firm primarily makes seed and start-up investments in the early-stage. Invest.BW is an incubator and an early-stage venture capital firm. It has invested in three portfolio startups. The firm is focused on investing in innovative companies and is located in Baden-Württemberg, Germany



Collaborative projects

The Walloon Region, The Walloon Region – Belgium (DGO6) granted subsidies to Cellaïon to develop its signaling cell technology and conduct clinical studies for targeted indications.

L’Agence Wallonne à l’Exportation et aux Investissements Étrangers (AWEX) – Belgium supports the international development of Cellaïon.

Current partnership

Cellaïon has an ongoing collaboration with the founding Laboratory of Pediatric Hepatology and Cellular Therapy of the Experimental Clinical and Research Institute (IREC, PEDI pole) at UCLouvain, Brussels, Belgium.


Cellaïon as partner

The Walloon regional government

AWEX, which promotes foreign trade and investments in Wallonia.

BioWin , the driving force for medical biotechnology and health technology growth in Wallonia.

Furthermore, Belgium’s location in the heart of Europe facilitates exceptional transport links across the world, providing an ideal infrastructure for the distribution of goods from our manufacturing sites to treatment centers.

Cellaïon is looking to use its outstanding capabilities and expertise in liver biology and cell-based medicine, along with its strong scientific, preclinical and early-stage clinical development expertise, to build strategic collaborations .